Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

What's Behind Bio-Rad Laboratories' Q4 Earnings Miss


Bio-Rad Laboratories (NYSE: BIO) delivered a fantastic performance in 2019, with shares skyrocketing 59%. But so far this year, the stock hasn't gotten off to a great start.

The company announced its 2019 fourth-quarter and full-year results after the market closed on Thursday. Here are the highlights from Bio-Rad's Q4 update.

Image Source: Getty Images.

Continue reading


Source Fool.com

Like: 0
BIO
Share

Comments